EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Haoyu Fang, Haoying Xu, Jiong Yu, Hongcui Cao iD, Lanjuan Li

Biomolecules · 04.07.2024 · 14 (7) · 794

DOI: 10.3390/biom14070794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 04.07.2024. Verfasst von Haoyu Fang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Pathophysiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China. Hauptthemen laut MEDLINE: Organoids, Drug Evaluation, Preclinical, Liver. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Project of Jinan Microecological Biomedicine Shandong Laboratory, Fundamental Research Funds for the Central Universities, High-level personnel cultivating project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many drug and therapeutic modalities have emerged over the past few years. However, successful commercialization is dependent on their safety and efficacy evaluations. Several preclinical models are available for drug-screening and safety evaluations, including cellular- and molecular-level models, tissue and organoid models, and animal models. Organoids are three-dimensional cell cultures derived from primary tissues or stem cells that are structurally and functionally similar to the original organs and can self-renew, and they are used to establish various disease models. Human hepatobiliary organoids have been used to study the pathogenesis of diseases, such as hepatitis, liver fibrosis, hepatocellular carcinoma, primary sclerosing cholangitis and biliary tract cancer, as they retain the physiological and histological characteristics of the liver and bile ducts. Here, we review recent research progress in validating drug toxicity, drug screening and personalized therapy for hepatobiliary-related diseases using human hepatobiliary organoid models, discuss the challenges encountered in current research and evaluate the possible solutions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsDrug Evaluation, PreclinicalLiverHumansAnimalsBiliary Tract

Stichwörter der Autor:innen

drug screeninghepatobiliary organoidshuman tissue-derived organoidspersonalized medicinepreclinical modeltoxicity verification

Autor:innen und Institutionen

  • Department of Pathology and Pathophysiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
  • Jinan Microecological Biomedicine Shandong Laboratory, Jinan 250117, China.
  • State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center fo…
  • Zhejiang Key Laboratory for Diagnosis and Treatment of Physic-Chemical and Aging-Related Injuries, 79 Qingchun Rd., Hangzhou 310003, China.

ORCID-Profile: Hongcui Cao

Förderung

  • Research Project of Jinan Microecological Biomedicine Shandong Laboratory
  • Fundamental Research Funds for the Central Universities
  • High-level personnel cultivating project of Zhejiang Province
  • Shandong Provincial Laboratory

Zitieren

APA

Fang, H., Xu, H., Yu, J., Cao, H., & Li, L. (2024). Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening. Biomolecules, 14(7), 794. https://doi.org/10.3390/biom14070794

Vancouver

Fang H, Xu H, Yu J, Cao H, Li L. Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening. Biomolecules. 2024;14(7):794. doi:10.3390/biom14070794

BibTeX
@article{Fang2024,
  author = {Fang, Haoyu and Xu, Haoying and Yu, Jiong and Cao, Hongcui and Li, Lanjuan},
  title = {Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {794},
  doi = {10.3390/biom14070794}
}
Kostenlos starten →